US 8969359
Gyrase and topoisomerase IV inhibitors
granted A61PA61P1/00A61P1/02
Quick answer
US patent 8969359 (Gyrase and topoisomerase IV inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Mar 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61P, A61P1/00, A61P1/02, A61P11/00, A61P13/02